[Long-term Courses of Bipolar Disorders]

Overview

Journal Nervenarzt

Specialty Neurology

Date 2024 Dec 21

PMID 39709326

Authors

Tabea Czempiel

Pavol Mikolas

Michael Bauer

Sabrina Vogel

Philipp Ritter

Affiliations

Soon will be listed here.

Abstract

Background: Bipolar disorder (short: BD) is a severe illness with very heterogeneous trajectories. While some of the patients show no or hardly any long-term impairments, other affected individuals show substantial neurocognitive deficits with a clear decline in psychosocial functioning. Which factors influence the course of the disease is the subject of current research efforts.

Objective: This review presents the long-term course of bipolar disease and the factors influencing it. In particular, differential trajectory types are discussed. The cognitive and psychosocial functional level as well as the psychopathological characteristics of the disease are elucidated. In addition, biological factors and treatment approaches influencing the course and prognosis are identified.

Material And Methods: Literature search using PubMed focusing on longitudinal studies over several years (see online supplement).

Results: To date, there are only a few predictors and biomarkers that allow prediction of long-term progression. None have been sufficiently studied to enable clinical use. Appropriate pharmacological and psychotherapeutic treatment of those affected is essential to avoid renewed episodes of the disease.

Discussion: The long-term course of bipolar disorder is highly heterogeneous and multifaceted. Despite intensive research efforts, no predictors have yet been identified that reliably predict the clinical course. This makes further research all the more important in order to offer individualized therapy options, develop new therapies and positively influence the course of the disease at an early stage.

References

Arvilommi P, Pallaskorpi S, Linnaranta O, Suominen K, Leppamaki S, Valtonen H . Long-term work disability due to type I and II bipolar disorder: findings of a six-year prospective study. Int J Bipolar Disord. 2022; 10(1):19. PMC: 9271449. DOI: 10.1186/s40345-022-00264-6. View

Jones G, Vecera C, Pinjari O, Machado-Vieira R . Inflammatory signaling mechanisms in bipolar disorder. J Biomed Sci. 2021; 28(1):45. PMC: 8194019. DOI: 10.1186/s12929-021-00742-6. View

Frigerio S, Strawbridge R, Young A . The impact of caffeine consumption on clinical symptoms in patients with bipolar disorder: A systematic review. Bipolar Disord. 2020; 23(3):241-251. DOI: 10.1111/bdi.12990. View

Nierenberg A, Agustini B, Kohler-Forsberg O, Cusin C, Katz D, Sylvia L . Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA. 2023; 330(14):1370-1380. DOI: 10.1001/jama.2023.18588. View

Maden A, Skapinakis P, Lewis G, Scott F, Jamieson E . Gender differences in reoffending after discharge from medium-secure units. National cohort study in England and Wales. Br J Psychiatry. 2006; 189:168-72. DOI: 10.1192/bjp.bp.105.014613. View

Hajek T, Franke K, Kolenic M, Capkova J, Matejka M, Propper L . Brain Age in Early Stages of Bipolar Disorders or Schizophrenia. Schizophr Bull. 2017; 45(1):190-198. PMC: 6293219. DOI: 10.1093/schbul/sbx172. View

Hibar D, Westlye L, van Erp T, Rasmussen J, Leonardo C, Faskowitz J . Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016; 21(12):1710-1716. PMC: 5116479. DOI: 10.1038/mp.2015.227. View

Macneil C, Hasty M, Cotton S, Berk M, Hallam K, Kader L . Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study. Early Interv Psychiatry. 2012; 6(4):380-8. DOI: 10.1111/j.1751-7893.2011.00336.x. View

Miklowitz D, Efthimiou O, Furukawa T, Scott J, McLaren R, Geddes J . Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis. JAMA Psychiatry. 2020; 78(2):141-150. PMC: 7557716. DOI: 10.1001/jamapsychiatry.2020.2993. View

Sonderby I, Gustafsson O, Doan N, Hibar D, Martin-Brevet S, Abdellaoui A . Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Mol Psychiatry. 2018; 25(3):584-602. PMC: 7042770. DOI: 10.1038/s41380-018-0118-1. View

Frank E, Soreca I, Swartz H, Fagiolini A, Mallinger A, Thase M . The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am J Psychiatry. 2008; 165(12):1559-65. PMC: 3308335. DOI: 10.1176/appi.ajp.2008.07121953. View

Reinares M, Vieta E, Colom F, Martinez-Aran A, Torrent C, Comes M . What really matters to bipolar patients' caregivers: sources of family burden. J Affect Disord. 2006; 94(1-3):157-63. DOI: 10.1016/j.jad.2006.04.022. View

McIntyre R, Berk M, Brietzke E, Goldstein B, Lopez-Jaramillo C, Kessing L . Bipolar disorders. Lancet. 2020; 396(10265):1841-1856. DOI: 10.1016/S0140-6736(20)31544-0. View

10.

Baldessarini R, Undurraga J, Vazquez G, Tondo L, Salvatore P, Ha K . Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand. 2011; 125(4):293-302. DOI: 10.1111/j.1600-0447.2011.01818.x. View

10.

Chakrabarty T, Harkness K, McInerney S, Quilty L, Milev R, Kennedy S . Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychol Med. 2019; 50(15):2536-2547. DOI: 10.1017/S003329171900268X. View

11.

Fernandes B, Steiner J, Molendijk M, Dodd S, Nardin P, Goncalves C . C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016; 3(12):1147-1156. DOI: 10.1016/S2215-0366(16)30370-4. View

12.

Papiol S, Schulze T, Heilbronner U . Lithium response in bipolar disorder: Genetics, genomics, and beyond. Neurosci Lett. 2022; 785:136786. DOI: 10.1016/j.neulet.2022.136786. View

13.

Aldinger F, Schulze T . Environmental factors, life events, and trauma in the course of bipolar disorder. Psychiatry Clin Neurosci. 2016; 71(1):6-17. PMC: 7167807. DOI: 10.1111/pcn.12433. View

13.

Miklowitz D, Furukawa T, Cipriani A . Interpreting the Findings of a Meta-analysis of Psychosocial Interventions in Bipolar Disorder. JAMA Psychiatry. 2021; 78(4):448-449. PMC: 8173773. DOI: 10.1001/jamapsychiatry.2020.4424. View

14.

Gimeno D, Kivimaki M, Brunner E, Elovainio M, De Vogli R, Steptoe A . Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2008; 39(3):413-23. PMC: 2788760. DOI: 10.1017/S0033291708003723. View